Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
JCI Insight|January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantationXing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2020
Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell TransplantationQiao-Zhu Zeng, Yuan-Yuan Zhang, Ye-Jun Wu, et al.
Current Medical Science|June 29, 2021
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic LeukemiaZhi-Dong Wang, Yue-Wen Wang, Lan-Ping Xu, et al.
Stem Cells and Development|September 27, 2017
Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling PathwayLin-Lin Xu, Hai-Xia Fu, Jia-Min Zhang, et al.
Transplantation and Cellular Therapy|March 30, 2021
Acute Cholecystitis Following Allogeneic Hematopoietic Stem Cell Transplantation: Clinical Features, Outcomes, Risk Factors, and Prediction ModelZhuangyi Zhang, Yun He, Xiao-Lu Zhu, et al.
Annals of Hematology|August 1, 2020
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantationXing-Ye Meng, Hai-Xia Fu, Xiao-Lu Zhu, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
JCI Insight|January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantationXing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2020
Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell TransplantationQiao-Zhu Zeng, Yuan-Yuan Zhang, Ye-Jun Wu, et al.
Current Medical Science|June 29, 2021
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic LeukemiaZhi-Dong Wang, Yue-Wen Wang, Lan-Ping Xu, et al.
Stem Cells and Development|September 27, 2017
Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling PathwayLin-Lin Xu, Hai-Xia Fu, Jia-Min Zhang, et al.
Transplantation and Cellular Therapy|March 30, 2021
Acute Cholecystitis Following Allogeneic Hematopoietic Stem Cell Transplantation: Clinical Features, Outcomes, Risk Factors, and Prediction ModelZhuangyi Zhang, Yun He, Xiao-Lu Zhu, et al.
Annals of Hematology|August 1, 2020
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantationXing-Ye Meng, Hai-Xia Fu, Xiao-Lu Zhu, et al.
Pageof 24